The urologists have several options for treating ureteral stones in the range of 8-15mm. Of that range, this study makes a comparison between ESWL and ureteroscopic holmium laser lithotripsy in the treatment of ureteric stone. In spite of that ureteroscopy and ESWL are invasive procedures, still there is controversy which of them is more suitable for treating ureteral stones condition. Study Aim: This study conducts a review to compare the effectiveness, safety and complications of using ureteroscopic holmium laser lithotripsy and ESWL in treating of ureteral stones. Study Methods: Eighty ureteroscopic holmium laser lithotripsy or ESWL-treated patients between April 2016 and April 2017 in Al-Diwaneyah teaching hospital who is having 8–14mm single radiopaque ureteral stone, were assessed. All of the patients in the study sample were subjected to follow-up period of seven months using ultrasonography. Then, comparison was made to identify stone clearance rate, potential complications and cost. Study Results: Results show that There is resemblance in treatment time and stone clearance rate between the two treatments. Generally, the total cost, the procedural time and analgesia requirements and were noticeably variant. Additionally, gross hematuria and renal colic were more frequent with ESWL procedure, while the voiding symptoms show more frequency with ureteroscopy procedure. The two procedures that were applied for the treatment of 8-14mm range ureteral stones proved to be the least invasive and secure.

To assess the benefit and safety of composite therapy (Tamsulosin and Trospium drugs) in treating benign prostatic enlargement complain, mainly overactive urinary bladder symptoms. OBJECTIVE: The study has been designed to estimate the benefit and safety of Trospium and Tamsulosin in processing of symptoms of excessive bladder and benign prostate hyperplasia (BPH). Patients and Methods: Prospective clinical trial study conducted at Al-Diwaniya teaching hospitals and private clinics from march 2016 to march 2017, to patients BPH and bothersome symptoms. 60 patients were treated with Tamsulocin and 60 patients were treated by Tamsulocin and Trospium. RESULTS: Median scores of IPSS, OABSS, and QOL proved no big difference between two study sets before staring treatment (P = 0.544), (P = 0.287) , (P = 0.668) consecutively. After one month, both treatments led to a big reduction in IPSS, OABSS median score; (P < 0.001), (P < 0.001). Following three months, both treatments resulted in significant reduction in IPSS (P < 0.001), OABSS (P < 0.001), QOL result, (P < 0.001) consecutively. Conclusion: These results suggest which treatment with Trospium and tamsulosin therapy provides benefit for men with natural - Syndrome of the acute urinary tract and benign enlarged prostate.

Objectives:The objectives of this study were to study the efficacy of diode laser prostatectomy in patients infected with benign prostatic enlargement.Methods: A total of 62 men were included in our prospective clinical study from August 2017 to January 2018. The size of their prostates (ml) was ranged from 38 to 65, digital rectal examination for all patients was revealed the features of benign prostatic enlargement, prostate-specific antigen was ranged from 0.3 to 14 ng/ml, underwent laser prostatectomy (Diode laser). Results:The study included 62 men with 67.82±7.57 years. After the operation, the median maximum flow rate (Qmax) was increased 11-22 ml/s and the increment was highly significant (p<0.001), and median international prostate symptom score was highly significantly reduced from 19 to 10 (p<0.001). In addition, median residual volume was highly significantly reduced from 169.5 to 77 ml (p<0.001). Mean duration of operation was 67.82±7.57 min. The duration of catheterization with a mean of 1.16±0.45 days. Most patients required only 1 day of hospital stay postoperatively. No one developed post-operative bleeding, erectile dysfunction was reported in a single patient (1.6%), urinary incontinence in one patient (1.6%), and urinary tract infection was the most frequent post-operative complication being reported in 11.3%. Conclusion:Diode laser for the treatment of prostate is easily applicable, cheap and provides good ablation with low morbidity. Ali and ObaidTURP or open surgery. The mean duration of the urinary catheter was 1.16 day, and this is less than TURP or open surgery. Hospital stay is 1 day, and this is good, no post-operative bleeding. Erectile dysfunction after the procedure only 1.6%. Urinary tract infections are the main problem because of necrotic tissue.No mortality, very low morbidity with good outcome compared to other LASER procedures, and TURP make this procedure more preferable in spite of the standardization of TURP. CONCLUSIONDiode LASER for the treatment of prostate is easily applicable, cheap and provides good ablation with low blood loss.